Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT00902434
Eligibility Criteria:
Inclusion Criteria:
* Patients with any NHL diagnosis regardless of histology who are over the age of 80 at the time of diagnosis will be included and analyzed.
* Data on age, gender, performance status, and major co-morbid conditions will be collected.
* Histology of the diagnosed NHL will be recorded. The grade (1, 2, or 3) for those who were diagnosed with follicular lymphoma will also be recorded.
* Stage of the disease, presence of bulky nodes and B symptoms will also be recorded.
* PET scan results if available.
* Type of treatment received will be recorded.
* Responses to therapy.
* Outcomes of treatment implemented and toxicities incurred.
* Subsequent therapies if applicable.
Exclusion Criteria:
* None. All charts of patients who are above the age of 80 at the time of NHL diagnosis will be analyzed.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
80 Years
Maximum Age:
80 Years
Study:
NCT00902434
Study Brief:
Protocol Section:
NCT00902434